Pralurbactam clinical trials
Also written FL058.
How each study uses pralurbactam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the pralurbactam studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Beta-lactamase inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 2 in phase 3
Studies that test pralurbactam, phase 3 first.
- Dec 2026Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae InfectionsPhase 3 · Qilu Pharmaceutical Co., Ltd.
- May 2027Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAIPhase 3 · Qilu Pharmaceutical Co., Ltd.
Studies
Open first, then newest update. How each study uses pralurbactam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPRecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07327619Written as Meropenem and Pralurbactam
- Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae InfectionsRecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07089186Written as Meropenem and Pralurbactam
- Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAINot yet recruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT06633718Written as Meropenem and Pralurbactam
- Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)CompletedPhase 1Qilu Pharmaceutical Co., Ltd.NCT05058118Written as FL058
- Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)CompletedPhase 1Qilu Pharmaceutical Co., Ltd.NCT05058105Written as FL058 500mg and Meropenem 1000mg( IV 120min)
- Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)CompletedPhase 1Qilu Pharmaceutical Co., Ltd.NCT05055687Written as FL058
Codes
What other systems call pralurbactam · ClinicalTrials.gg INT016706
- UNII (FDA) GTP46AY74RPRALURBACTAMConfirmed FDA, Wikidata
- Wikidata Q140641177pralurbactamConfirmed FDA, Wikidata
- NCI Thesaurus C199094PralurbactamOne source FDA
- DrugBank DB19437One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | GTP46AY74R | PRALURBACTAM | Confirmed FDA, Wikidata |
| Wikidata | Q140641177 | pralurbactam | Confirmed FDA, Wikidata |
| NCI Thesaurus | C199094 | Pralurbactam | One source FDA |
| DrugBank | DB19437 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.